APA (7th ed.) Citation

Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Thanunrat Thongmee, . . . Yong Poovorawan. (2022). Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: A prospective cohort study. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Nasamon Wanlapakorn, et al. Safety and Immunogenicity of Heterologous and Homologous Inactivated and Adenoviral-vectored COVID-19 Vaccine Regimens in Healthy Adults: A Prospective Cohort Study. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Nasamon Wanlapakorn, et al. Safety and Immunogenicity of Heterologous and Homologous Inactivated and Adenoviral-vectored COVID-19 Vaccine Regimens in Healthy Adults: A Prospective Cohort Study. Taylor & Francis Group, 2022.